Biogen Inc (HAM:IDP)
€ 180.14 +4.62 (+2.63%) Market Cap: 26.26 Bil Enterprise Value: 28.27 Bil PE Ratio: 21.67 PB Ratio: 1.60 GF Score: 74/100

Biogen Inc Annual Shareholders Meeting Transcript

Jun 09, 2026 / 01:00PM GMT
Release Date Price: €169.16 (-0.07%)
Operator

Good day and welcome to the Biogen 2026 Annual Meeting of Stockholders.

I would now like to turn the conference over to Carolyn Dorsa. Please go ahead.

Caroline Dorsa
Biogen Inc - Independent Chairman of the Board

Thank you, Michael. Good morning. I am Carolyn Dorsa, Chair of the Board of Biogen, and I welcome you to Biogen's 2026 Annual Meeting of Stockholders.

I am here today with Wendell Taylor, Chief Corporate Counsel, who will act as Secretary of the meeting, and Christopher Viebacher, our President, Chief Executive Officer, and one of our Directors. I'm also joined by the other members of our board of directors, as well as members of the executive team of Biogen, including Ginger Gregory, Chief Human Resources Officer, Jane Grogan, Head of Research.

Rashid Izzar, Head of Global Product Strategy and Commercialization, Adam Kearney, Head of Corporate Development, Robin Kramer, Chief Financial Officer, Nicole Murphy, Head of Pharmaceutical Operations and Technology, and Priya Singhal, Head of Development. Mark Marsanti,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot